10x Genomics, Inc. Class A Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for TXG, updated each market day.
TXG AI Sentiment
AI predicts 10x Genomics, Inc. Class A Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About 10x Genomics, Inc. Class A Common Stock
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Sector
Exchange
Market Cap
$2,938,301,842
Cap Tier
Employees
1,178
Headquarters
PLEASANTON, CA
Listed Since
Sept. 12, 2019
Website
TXG Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TXG Volatility
10x Genomics, Inc. Class A Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
